• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Targeting CD28-CD86 Pathway for Refractory Myeloma Through CTLA4Ig-Based Reduced-Intensity Conditioning and Donor Lymphocyte Infusions After Haploidentical Transplantation.

作者信息

Jaiswal Sarita Rani, Bhakuni Prakash, Bansal Satish, Aiyer Hema Malini, Bhargava Sneh, Chakrabarti Suparno

机构信息

Cellular Therapy and Immunology, Manashi Chakrabarti Foundation, Kolkata, India; Department of Blood and Marrow Transplantation, Dharamshila Narayana Superspeciality Hospital and Research Centre, New Delhi, India.

Department of Blood and Marrow Transplantation, Dharamshila Narayana Superspeciality Hospital and Research Centre, New Delhi, India.

出版信息

Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):e430-e435. doi: 10.1016/j.clml.2019.04.008. Epub 2019 Apr 30.

DOI:10.1016/j.clml.2019.04.008
PMID:31129111
Abstract
摘要

相似文献

1
Targeting CD28-CD86 Pathway for Refractory Myeloma Through CTLA4Ig-Based Reduced-Intensity Conditioning and Donor Lymphocyte Infusions After Haploidentical Transplantation.通过单倍体移植后基于CTLA4Ig的低强度预处理和供体淋巴细胞输注靶向CD28-CD86通路治疗难治性骨髓瘤
Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):e430-e435. doi: 10.1016/j.clml.2019.04.008. Epub 2019 Apr 30.
2
Natural killer cell-based immunotherapy with CTLA4Ig-primed donor lymphocytes following haploidentical transplantation.采用 CTLA4Ig 预致敏供者淋巴细胞的基于自然杀伤细胞的免疫疗法，应用于单倍体相合移植后。
Immunotherapy. 2019 Oct;11(14):1221-1230. doi: 10.2217/imt-2019-0037. Epub 2019 Sep 3.
3
CTLA4Ig-based reduced intensity conditioning and donor lymphocyte infusions for haploidentical transplantation in refractory aggressive B-cell lymphoma relapsing after an autograft: Early results from a pilot study.基于 CTLA4Ig 的低强度预处理方案和供者淋巴细胞输注治疗自体移植后复发的难治性侵袭性 B 细胞淋巴瘤的单倍体相合移植：一项前瞻性研究的初步结果。
Exp Hematol. 2019 Sep;77:26-35.e1. doi: 10.1016/j.exphem.2019.08.002. Epub 2019 Aug 23.
4
Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation.接受氟达拉滨、阿糖胞苷和安吖啶联合治疗后进行减低强度预处理及异基因干细胞移植的难治性急性髓系白血病患者预后的危险因素。
J Cancer Res Clin Oncol. 2016 Jan;142(1):317-24. doi: 10.1007/s00432-015-2050-y. Epub 2015 Sep 30.
5
Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning.减低预处理强度后高危多发性骨髓瘤患者异基因移植的预后因素
Exp Hematol. 2003 Jan;31(1):73-80. doi: 10.1016/s0301-472x(02)01010-x.
6
Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents.日本儿童和青少年急性髓系白血病中，氟达拉滨与马法兰联合的低毒性预处理方案与放疗和/或白消安的清髓性预处理方案的比较。
Pediatr Blood Cancer. 2015 May;62(5):883-9. doi: 10.1002/pbc.25389. Epub 2014 Dec 24.
7
Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning.采用减低强度预处理的异基因干细胞移植治疗慢性淋巴细胞白血病后的治疗相关死亡率及移植物抗白血病活性
Leukemia. 2003 May;17(5):841-8. doi: 10.1038/sj.leu.2402905.
8
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.使用白消安、氟达拉滨和抗胸腺细胞球蛋白进行减低强度预处理用于缓解期急性髓系白血病患者接受无关或单倍体相合家庭供者造血细胞移植
Biol Blood Marrow Transplant. 2017 Sep;23(9):1555-1566. doi: 10.1016/j.bbmt.2017.05.025. Epub 2017 May 25.
9
Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.氟达拉滨与白消安的减低剂量预处理方案对比氟达拉滨与美法仑用于急性髓细胞白血病患者：欧洲血液与骨髓移植组急性白血病工作组的报告
Cancer. 2015 Apr 1;121(7):1048-55. doi: 10.1002/cncr.29163. Epub 2014 Nov 25.
10
Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC).低级别淋巴瘤减强度预处理异基因干细胞移植后的长期疗效：法国骨髓移植与细胞治疗协会（SFGM-TC）的一项调查
Haematologica. 2007 May;92(5):627-34. doi: 10.3324/haematol.10924.

引用本文的文献

1
Myxoma Virus Combination Therapy Enhances Lenalidomide and Bortezomib Treatments for Multiple Myeloma.黏液瘤病毒联合疗法增强来那度胺和硼替佐米对多发性骨髓瘤的治疗效果。
Pathogens. 2024 Jan 12;13(1):72. doi: 10.3390/pathogens13010072.
2
Facing challenges with hope: universal immune cells for hematologic malignancies.满怀希望应对挑战：用于血液系统恶性肿瘤的通用免疫细胞。
Cancer Biol Med. 2023 May 4;20(4):229-47. doi: 10.20892/j.issn.2095-3941.2022.0759.